decrease font size
increase font size
change type face
bookmark this page
email this page
print this page

ThePigSite Latest News

Search ThePigSite:
Section:

Use the above box to search this section or the whole site
Wednesday, October 12, 2005
Print This Page

Leading swine antibiotic Denagard acquired by Novartis

US - Denagard (tiamulin), a broad-spectrum swine antibiotic for control and treatment of certain swine bacterial diseases, has been purchased by Novartis Animal Health US, Inc.

Novartis Animal Health US, Inc.

The company announced that an agreement with Boehringer Ingelheim Vetmedica, Inc. was signed enabling Novartis to acquire the Denagard brand franchise.

According to Pedro Schmid, senior vice president of the Novartis U.S. farm animal business, the acquisition represents a significant step in the company's efforts to strengthen its position in the livestock industry, but more importantly, will help the company work more closely with swine producers to develop improved pig health programs.

"The purchase of Denagard enables Novartis to expand its offering to the U.S. pork industry and improve the value we bring to pork producers," Schmid explains. "Plus, it broadens our swine product portfolio with a product that we have significant experience with on a global basis."

Novartis pioneered tiamulin, the active ingredient in Denagard, and markets it under the Tiamutin brand name in other key swine markets throughout the world. It is a member of the pleuromutilin class of antibiotics, which is reserved worldwide for animal use and is not used in human medicine.

"For those pork producers who prefer to use a swine antibiotic that is of a class not used in human medicine, Denagard offers an excellent choice," says Gary Bosch, DVM, director of the swine business unit.

Denagard is a broad-spectrum antibiotic with formulations to treat both enteric and respiratory diseases. It has been used by many producers and has proven its value in ease of use, safety and efficacy in treating some of the most troublesome swine diseases, Bosch says.

Source: Novartis Animal Health US, Inc. - 10th October 2005



Our Newest
Web Site


TheBioenergySite

Saturday 11th October

Search Site